Insider Trading November 11, 2026 03:30 AM

SelectQuote COO William Grant Discloses $40,198 Share Purchase

Insider buy comes as stock trades at $0.46, down 71% over the past year, with a low Price/Book multiple of 0.26.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
SLQT

SelectQuote COO William Grant acquired 79,600 shares for $40,198 on November 6, 2026, at prices between $0.415 and $0.53. The purchase adds to his direct and indirect holdings, which include shares held through a trust, an IRA, and Haakon Capital, LLC. The transaction occurs as SelectQuote's stock trades at $0.46, down 71% over the past year, and at a low Price/Book multiple of 0.26. Separately, the company reported a first-quarter adjusted loss per share of $0.21, better than the expected $0.34 loss, while revenue of $280 million fell short of the $326.17 million forecast. Adjusted EBITDA loss improved by $15 million year over year to $17 million, and trailing 12-month adjusted EBITDA rose 30% to $124 million. Management maintained its fiscal 2027 operating cash flow guidance of at least $60 million. The company attributed weaker sales partly to a reduced agent force and the effects of the Inflation Reduction Act on Healthcare Services revenue, while emphasizing progress in profitability and continued focus on AI, automation, and a leaner agent force to protect margins.

SelectQuote COO William Grant Discloses $40,198 Share Purchase
SLQT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • SelectQuote COO William Grant bought 79,600 shares for $40,198 at prices between $0.415 and $0.53, adding to his direct and indirect holdings.
  • The insider purchase occurs as SLQT trades at $0.46, down 71% over the past year, and at a low Price/Book multiple of 0.26, which may suggest undervaluation.
  • SelectQuote's first-quarter adjusted loss per share of $0.21 beat expectations of $0.34, but revenue of $280 million missed the $326.17 million forecast; adjusted EBITDA loss improved by $15 million year over year to $17 million.

William Grant, Chief Operating Officer of SelectQuote, Inc. (NASDAQ:SLQT), has disclosed the acquisition of 79,600 shares of the company's common stock. The transaction, dated November 6, 2026, was executed at prices ranging from $0.415 to $0.53, for a total value of $40,198. The purchase was made at a time when SelectQuote's shares are trading at $0.46, representing a 71% decline over the past year. According to InvestingPro analysis, the stock may be undervalued at current levels. InvestingPro Tips also note that SLQT is trading at a low Price/Book multiple of 0.26, with 15 additional tips available to subscribers.

Following the transaction, Mr. Grant directly holds 3,468,094 shares of SelectQuote common stock. In addition, he has indirect beneficial ownership of 1,150,000 shares through his role as Trustee for the William Thomas Grant III Irrevocable Trust, and 10,681 shares through a Mainstar Trust IRA. Mr. Grant also indirectly holds 1,089,369 shares through Haakon Capital, LLC, an investment company in which he owns a one-third stake. He disclaims beneficial ownership of the shares held by Haakon Capital, LLC, except to the extent of his pecuniary interest.

In other recent developments, SelectQuote reported its first-quarter earnings, showing a narrower-than-expected loss. The company posted adjusted earnings of negative $0.21 per share, compared with analyst expectations of negative $0.34. Revenue, however, came in at $280 million, below the anticipated $326.17 million. The company's adjusted EBITDA loss improved by $15 million year over year, reaching $17 million, while trailing 12-month adjusted EBITDA increased by 30% to $124 million. Management reaffirmed its fiscal 2027 operating cash flow guidance of at least $60 million. Despite weaker sales, which were attributed in part to a reduced agent force and the effects of the Inflation Reduction Act on Healthcare Services revenue, the company highlighted progress in profitability. SelectQuote continues to focus on AI, automation, and a leaner agent force to protect its margins.

Risks

  • Revenue shortfall in the first quarter, attributed partly to a reduced agent force and the effects of the Inflation Reduction Act on Healthcare Services revenue, could pressure future sales.
  • The stock's 71% decline over the past year and low Price/Book multiple of 0.26 may reflect persistent valuation concerns despite the insider purchase.
  • The company's ability to achieve its fiscal 2027 operating cash flow guidance of at least $60 million depends on successful execution of its AI, automation, and leaner agent force strategy.

More from Insider Trading

Teradata CEO Offloads $325,100 in Stock Under Pre-Set Trading Plan Nov 11, 2026 Ceribell Director Joseph Taylor Offloads $277,644 in Stock as Shares Near 52-Week High Nov 11, 2026 Six Flags Executive Chair Haddrill Purchases $90,720 in Company Shares Nov 11, 2026 SelectQuote Director Donald Hawks III Boosts Stake with $114,218 Stock Purchase Nov 11, 2026 SelectQuote Insider Buying: President Grant Adds 79,801 Shares as Stock Trades Near $0.46 Nov 11, 2026